Elanco Reports the US FDA’s Review Completion of Bovaer to be Used Across the US Dairy Industry
Shots:
- The US FDA has completed the review of Bovaer (3-NOP), an FIC feed ingredient to minimize methane, and confirmed the product’s safety & effectiveness for its use in lactating dairy cattle
- Elanco collaborates with dsm-firmenich to expand Bovaer’s distribution in North America plus gains the right to market it across Canada & Mexico, where the product has been approved for beef & dairy cattle. The product launch with added carbon credit value to producers is anticipated in Q3’24
- Bovaer suppresses the methane-producing enzyme in the cow’s rumen. 1 tablespoon of it per lactating dairy cow per day minimizes 30% of methane emissions or 1.2 metric tons of carbon dioxide equivalent (CO2e) emissions, yearly
Ref: Elanco | Image: Elanco
Related News:- Merck Animal Health Reports Acquisition of Elanco Animal Health’s Aqua Business for ~$1.3B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
